OptimizeRx
OPRX
#8557
Rank
HK$1.56 B
Marketcap
HK$84.06
Share price
-0.55%
Change (1 day)
88.95%
Change (1 year)

Earnings for OptimizeRx (OPRX)

Earnings in 2025 (TTM): HK$56.99 Million

According to OptimizeRx's latest financial reports the company's current earnings are HK$0.10 Billion. In 2024 the company made an earning of -HK$0.11 Billion, an increase over its 2023 earnings that were of -HK$0.17 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for OptimizeRx from 2008 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) HK$56.99 M-155.17%
2024 -HK$0.11 Billion-38.79%
2023 -HK$0.17 Billion75.76%
2022 -HK$96.03 Million-3503.68%
2021 HK$2.82 M-116.91%
2020 -HK$16.69 Million-36.13%
2019 -HK$26.12 Million-515.42%
2018 HK$6.28 M-138.25%
2017 -HK$16.44 Million36.7%
2016 -HK$12.03 Million159.05%
2015 -HK$4.65 Million-49.7%
2014 -HK$9.23 Million280.42%
2013 -HK$2.43 Million-14.74%
2012 -HK$2.85 Million-76.84%
2011 -HK$12.29 Million-17.37%
2010 -HK$14.88 Million
2008 -HK$33.27 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Park City Group
PCYG
HK$47.56 M-16.63%๐Ÿ‡บ๐Ÿ‡ธ USA
LivePerson
LPSN
-HK$0.46 Billion-904.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Brightcove
BCOV
-HK$62.76 Million-209.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Crexendo
CXDO
HK$36.21 M-36.52%๐Ÿ‡บ๐Ÿ‡ธ USA